The human embryonal carcinoma cells NEC14 can be induced to dierentiate morphologically by the addition of 10 72 M N, N'-hexamethylene-bis-acetamide and cease to grow in several days. Transcription factors of the E2F/DP family have been shown to be closely related to the regulation of cell proliferation. To analyse cellular proteins which interact with E2F in NEC14 cells, cDNA clones encoding E2F binding proteins were isolated from a lZAP II NEC14 cell library with the 32 P-labeled GST (Glutathione S-transferase)-E2F-1 fusion protein as a probe. One of the clones encodes E2FBP1 which has the helix ± loop ± helix (HLH) motif, but lacks the basic domain and the zipper structure usually found at N-and C-terminal sides to the HLH motif, respectively. The arrangement of amino acids in the helix 1 and helix 2 regions is quite similar to those of Mxi and Mad, but dierent from those of E2F-1 and DP-1. Western blot analysis of the immunoprecipitates prepared with anti-E2FBP1 antibody showed that E2FBP1 associates with both E2F-1 and DP-1 in vivo. E2FBP1 alone has no DNA binding activity, but bind to the E2F site through heterodimerization with E2F-1 but not with DP-1. Although E2FBP1 lacks the transactivation domain, it stimulates E2F site-dependent transcription in cooperation with E2F-1.
Introduction
The transcription factor E2F was ®rst identi®ed as a cellular factor involved in the activation of the viral E2 promoter in adenovirus-infected cells (Kovesdi et al., 1986) . The E2F recognition sequence has been found in the promoters of many cell cycle-regulated genes (Nevins, 1992) encoding such as DNA polymerase a (Peason et al., 1991) , dihydrofolate reductase (DHFR) (Blake and Azizkhan, 1989) and cdc2 (Dalton, 1992) , that are activated at the G1/S boundary. Expression of these genes is restrained during early to mid G1 phase at least in part, by sequestering E2F through formation of the complexes with retinoblastoma protein (pRB) and its related proteins p107 and p130 (Weinberg, 1995) . The complexes inactivate the E2F transactivation function and act as a repressor (Hamel et al., 1992; Hiebert et al., 1992; Zamanian and La Thangne, 1993; Zhu et al., 1993 ). An active form of free E2F seems to be released from these complexes upon phosphorylation of pRB, p107 and p130 by various cyclin-dependent kinases during mid to late G1 phase (Weinberg, 1995) . Expression of E2F-responsive genes declines as S phase proceeds by inactivation of E2F-1 DNA-binding activity through phosphorylation by cyclin A/cdk2 kinase (Krek et al, 1994; Xu et al., 1994) .
The structural features of E2F have been analysed by cloning the cDNA encoding a pRB binding protein with many of the properties of authentic E2F (Helin et al., 1992; Kaelin et al., 1992; Shan et al., 1992) . The protein, called E2F-1 contains basic ± helix ± loop ± helix (bHLH)-hydrophobic zipper structure required for DNA binding and dimerization in the central portion and the transactivation domain in the C-terminal portion of the molecule. The pRB binding site is located within the transactivation domain. Many cDNA clones encoding E2F-related proteins have been isolated thereafter, revealing multiple members of the family. One of the proteins referred to as DP-1 (dierentiation regulated transcription factor, DRTF1) was originally characterized as a transcription factor whose DNA binding activity decreased during differentiation of F9 mouse embryonal carcinoma (EC) cells (Girling et al., 1993) . E2F-1 and DP-1 form a heterodimer which has greater DNA binding activity than does each homodimer (La Thangue, 1994) . E2F-1 and DP-1 exist as a complex in vivo and act synergistically in E2F site-dependent transcriptional activation Krek et al., 1993) . E2F activity is therefore assumed to be generated by the formation of heterodimers between an E2F-1 related protein and a DP-1 related protein.
Both factors seem to consist of many members of the family, and E2F-1 related proteins of E2F-2, E2F-3, E2F-4 and E2F-5 (Ivey-Hoyle et al., 1993; Ginsberg et al., 1994; Beijersbergen et al., 1994; Sardet et al., 1995; Hijmans et al., 1995; Buck et al., 1995) and DP-1 related proteins of DP-2 and DP-3 (Wu et al., 1995; Zhang and Chellappan, 1995; Ormondroyd et al., 1995) have been identi®ed. E2F-1 is expressed at a low level in quiescent cells, but induced in late G1 phase after mitogen treatment . E2F-1, E2F-2 and E2F-3 preferentially bind to pRB and E2F-4 to p107. In contrast, DP-1 is expressed throughout the cell cycle and binds to both pRB and p107 (La Thangue, 1994) . These ®ndings suggest the presence of multiple species of heterodimers and that an individual heterodimer has a distinct role in the E2F-regulated transcription of the cell cycle genes.
The human embryonal carcinoma (EC) cell line, NEC14, established from a testicular germ cell tumor (Sekiya et al., 1985) , can be induced to dierentiate by the addition of 10 72 M N,N'-hexamethylene-bis-acetamide (HMBA) in vitro (Hasegawa et al., 1991) and cease to grow in several days. To analyse heterodimeric partners of E2F in human EC cells, the cDNA clones encoding E2F-1 binding proteins were isolated from an E. coli cDNA expression library prepared from dierentiating NEC14 cells. One of the cDNA clones encodes E2FBP1, which binds to E2F-1 and DP-1 both in vivo and in vitro through the HLH motif, but lacks the basic domain and the zipper structure. The arrangement of amino acids within the HLH motif is similar to those of Mxi and Mad, but dierent from those of E2F-1 and DP-1. The properties of E2FBP1 and its cooperative action with E2F-1 on the E2F site-dependent transcription were analysed.
Results

Structural features of E2F-binding protein-1
To analyse cellular proteins that interact with E2F in human EC cells, a lZAPII cDNA expression library was constructed from the mixture of NEC14 cells treated with HMBA for varying times and screened by using 32 P-labeled GST-E2F-1 fusion protein as the probe. One of the positive clones isolated contained a cDNA insert of 1.6 kb. The analysis of its structural features revealed a continuous open reading frame of 409 amino acids (Figure 1a) . The ®rst ATG codon has the Kozak motif and the protein encoded was eciently expressed and cooperated with E2F-1 in transactivation as shown in a later section. This protein was termed E2FBP1. The predicted amino acid sequence is 26% homologous to those of E2F-1 and DP-1 suggesting that E2FBP1 is not a member of the E2F/DRTF family. A search of the protein data base (GenBank) with the predicted E2FBP1 sequence revealed no identities. The amino acid sequence of E2FBP1 required for protein-protein interactions was ®rst searched by comparison of the sequence with those of the HLH motifs of E2F, Myc and E type bHLH protein family members. An amino acid alignment in the HLH regions of these proteins is shown in Figure 1b . Amino acid sequence of E2FBP1 from position 260 ± 299 contains two helix domains that are separated by a linker of 14 amino acids. The sequences of the helix 1 and helix 2 are most similar to those of Mxi 1 (Zervos et al., 1993) and Mad (Ayer et al., 1993) . The seven residues of either basic, acidic or hydrophobic amino acids shown in the black box within the E2FBP1 helix 1 just correspond to those found within the helix 1 of Mxi 1 and Mad. The four hydrophobic and one basic amino acid residues within the E2FBP1 helix 2 also correspond to those found within the helix 2 of Mxi 1 and Mad. Much less similarity is observed between E2FBP1 and E2F-1 and only two leucine residues within the helix 1 and two hydrophobic amino acid residues within the helix 2 are identical between them. Nearly no similarity is detected in the amino acid sequences of the HLH regions between E2FBP1 and DP-1.
E2FBP1 lacks the basic region characteristic of HLH transcription factors. The present no basic amino acid within the 19 residues N-terminal to the end of the helix 1. In contrast, eight basic amino acids are present within the corresponding 19 residues of E2F-1, and ®ve basic amino acids in the corresponding 13 residues of Mxi 1 and Mad. E2FBP1 also lacks the heptad repeat of the hydrophobic amino acids which comprises the zipper structure in the adjacent sequence C-terminal to the end of the helix 2. The zipper structure also concerns with the dimerization and is one of the motifs characteristics of the members of the E2F and Myc families. In E2FBP1, six hydrophobic amino acids are repeated every eight residues except one interval in the N-terminal region. This repeat, however, may not be involved in the dimerization, since these hydrophobic amino acids are not aligned on the same side of helix every other turn. There are two potential phosphorylation sites for cAMP-dependent kinase, (Kennelly and Krebs, 1991) and one potential site for casein kinase II (Elizabeth et al., 1987) as shown in Figure 1a . No potential site for cyclin-dependent kinase (cdk) (Shenoy et al., 1989) is present in contrast to the members of the E2F-1 family that have two potential sites for cdk (Shan et al., 1992) . E2FBP1 contains neither the sequence enriched with acidic amino acid residues required for the transactivation function nor the LXCXE pRB-binding motif usually found within the acidic region.
E2FBP1 heterodimerizes with E2F-1 through its HLH motif
To determine whether the HLH motif of E2F-1 is required for binding to E2FBP1, the fragments of E2F-1 cDNA, encoding the central 195 amino acids (aa 90 ± 284) and the C-terminal 153 amino acids (aa 285 ± 437) were cloned into the pGEX-2TK vector (Kaelin et al., 1992) to generate pGST-E2Fc and pGST-E2Fd, respectively (Figure 2a) . The former contains the HLH motif, and the latter contains the pRB binding motif. pGST-E2Fb contains both motifs. The nucleotide sequence corresponding to amino acid (aa) sequence RRASV for recognition by the catalytic subunit of cAMP-dependent protein kinase (A kinase) (Rashidbaigia et al., 1985; Blanar and Rutter, 1992) was placed between GST sequence and the E2F-1 fragment. These fusion proteins were expressed in E. coli, puri®ed and phosphorylated by A kinase. The plaque-puri®ed recombinant phages carrying the E2FBP1 cDNA were plated and expression of the bgal-E2FBP1 fusion protein was induced by overlaying the plate with the ®lter dipped in IPTG solution. The ®lter was then cut into four pieces and each piece was probed with either 32 P-labeled GST-E2Fb, GST-E2Fc, GST-E2Fd or GST. Protein localization was deter- P⋅GST, suggesting that E2F-1 binds to E2FBP1 through its HLH motif.
To identify the E2F-1 binding site of E2FBP1, three fragments of E2FBP1 cDNA, encoding the Nterminal, central and C-terminal portion, were similarly cloned into the pGEX-2TK vector to generate pGST-BP1b, pGST-BP1c and pGST-BP1d, respectively (Figure 3a) . pGST-BP1b contains the helix 1 sequence except two amino acid residues of C-terminal side but lacks the helix 2 sequence, while pGST-BP1d contains the helix 2 sequence, but lacks most of the helix 1 sequence. Both pGST-BP1a and pGST-BP1c contain the complete HLH motif. These fusion proteins were puri®ed and subjected to electrophoresis on a SDS-polyacrylamide gel. The proteins were denatured in 6 M guanidinium hydrochloride solution and renatured in its serially diluted solutions after transfer to the nitrocellulose ®lter, and probed with 32 P-labeled GST-E2Fb. E2FBP1 fragments bound to GST-E2Fb were detected by autoradiography. As shown in Figure 3b , GST-BP1a and GST-BP1c, both having the complete HLH motif, bound to GST-E2Fb tightly, while GST-BP1d having a large deletion in the helix 1 bound poorly. No binding was observed with GST-BP1b. The result strongly suggests that E2FBP1 binds to E2F-1 through its HLH motif.
E2FBP1 interacts with E2F-1 and DP-1 in vivo
To determine whether E2FBP1 interacts with E2F-1 and DP-1 in vivo, rabbits were immunized with GST-E2FBP1 fusion protein, and the resulting sera were ®rst tested for its crossreactivity by Western blotting. As shown in Figure 4a , anti-E2F-1 antibody KH95 (Santa Cruz Biotech.) recognized GST-E2F-1, but not GST-E2FBP1 and GST. Similarly, anti-E2FBP1 antibody recognized only GST-E2FBP1, and no crossreaction to E2F-1 was observed. The antibody neither recognized DP-1 (data not shown). E2FBP1 was electrophoresed slightly faster than E2F-1, re¯ecting its molecular mass slightly smaller than E2F-1.
The association of E2FBP1 with E2F-1 and DP-1 in vivo was analysed by Western blotting of the immunoprecipitates prepared with antibodies to E2F-1 and E2FBP1. As shown in Figure 4b , large amounts of E2F-1, E2FBP1 and DP-1 were present in the NEC14 cell extract as revealed with corresponding antibodies (lanes 1, 4 and 7). Both E2F-1 and DP-1 were present in the immunoprecipitate prepared with anti-E2FBP1 antibody (lanes 3 and 9). In the converse experiment, E2FBP1 was detected in the immunoprecipitate prepared with anti-E2F-1 antibody (lane 5). The result indicates that E2FBP1 binds to both E2F-1 and DP-1 in vivo presumably by forming heterodimers.
DNA binding activities of E2F-1/E2FBP1 and E2FBP1/ DP-1 heterodimers
To analyse the binding activity of the E2F-1/E2FBP1 heterodimer to the E2F site, the 32 P-labeled 42 bp oligonucleotide containing the two overlapping E2F binding sites in the human N-myc promoter was incubated with the NEC14 nuclear extract (4 mg of protein) in the presence of antibodies raised against E2F-1, DP-1 and E2FBP1 and the complexes formed were analysed by EMSA (Figure 5a ). Two complexes designated I and II were formed in the absence (lane 1) and presence (lane 3) of preimmune rabbit serum. The formation of these complexes was completely abolished by the presence of an excess of the same unlabeled oligonucleotide (lane 2). In the presence of anti-E2F-1 antibody (lane 5), almost all of the complex II was supershifted to the complex II' which migrated much slower than the complex II. In contrast, in the presence of either anti-E2FBP1 antibody or anti-DP-1 antibody, about a half or more of the complex II was supershifted to the complex II' (lanes 4 and 6). These three antibodies supershifted the complex II to the Figure 3 The E2FBP1 domain required for binding to E2F-1. (a) Structures of GST-E2FBP1 deletion constructs. The E2FBP1 cDNA fragments were similarly inserted into pGEX-2TK as described in Figure 2a . (b) GST fusion proteins containing the fragments of E2FBP1 as indicated (each 500 ng) were electrophoresed on a SDS-10% polyacrylamide gel and transferred to the nitrocellulose ®lter. After denaturation and renaturation of the proteins as described in`Materials and methods,' they were probed with 32 P-labeled GST-E2Fb. Probe localization was determined by autoradiography. Lane 2, GST; lane 3, GSTBP1a; lane 4, GST-BP1b; lane 5, GST-BP1c; lane 6, GST-BP1d, lane 1, size markers (M) same distance. The result suggests that the complex II consists of two types of complex; one was associated with E2F-1/DP-1 heterodimer and the other was associated with E2F-1/E2FBP1 heterodimer. No supershift was observed with preimmune rabbit serum (lane 3). The E2F complexes I and II were also formed with the cell extracts prepared from 293 (human embryo ®broblast transformed by adenovirus E1A and E1B genes), TIG (human diploid ®broblast), KB (human epidermoid carcinoma), and HT1080 (human fibrosarcoma) cells (data not shown).
To determine the formation of the E2F/E2FBP1 complex at the E2F site directly, GST-E2F-1, GST-DP-1, GST-E2FBP1, GST and combinations of these proteins were incubated with the 32 P-labeled oligonucleotide and the complexes formed were similarly analysed by EMSA. As shown in Figure 5b , GST-E2F-1 alone bound to DNA, presumably by forming the homodimer (lane 3), and the binding was unaected by the presence of GST (lane 6). Neither GST-E2FBP1, GST-DP-1, nor GST alone bound to DNA (lanes 2, 4 and 5). The inability of GST-E2FBP1 and GST-DP-1 to bind DNA was unaected by the presence of GST (lanes 7 and 8). Incubation of GST-E2F-1 together with GST-E2FBP1 or GST-DP-1 formed similar DNA complexes (lanes 9 and 10), but the complex formed with GST-E2F-1 and GST-DP-1 moved slightly faster than the complex formed with GST-E2F-1 and GST-E2FBP1. The formation of both complexes and their mobilities were unaected by the presence of GST (lanes 12 and 13). No complex was formed with a combination of GST-E2FBP1 and GST-DP-1 irrespective of the presence of GST (lanes 11 and 14) . Incubation of the mixture of GST-E2F-1, GST-E2FBP1 and GST-DP-1 in the absence (lane 15) or presence (lane 16) of GST formed a broad complex presumably consisting of two types of complex; one associated, with GST-E2F-1/GST-E2FBP1 and the other associated with GST-E2F-1/GST-DP-1.
Eect of the concentrations of GST-E2FBP1 and GST-DP-1 on the formation of the complex with GST-E2F-1 was addressed by forming the complex with the same 32 P-labeled oligonucleotide, a constant amount of GST-E2F-1 (2 mg) and increasing amounts of either GST-E2FBP1 or GST-DP-1 (Figure 6b,c) . The amounts of the complexes formed increased along with the increase in the amounts of GST-E2FBP1 and GST-DP-1, however, the increase caused by GST-E2FBP1 was smaller than that caused by GST-DP-1. The addition of increasing amounts of GST instead of GST-E2FBP1 and GST-DP-1 resulted in a slight decrease in the amounts of the E2F-1 complex formed (Figure 6a ). When constant amounts of GST-E2F-1 and GST-DP-1 (each 2 mg) were incubated with increasing amounts of GST-E2FBP1, a broad complex was formed along with the increase in the amounts of GST-E2FBP1 (Figure 6d ) and the complex was broadened at the slow-migrating side, suggesting again that the broad complex consists of two complexes; one formed with E2F-1/E2FBP1 and the other with E2F-1/ DP-1.
Expression levels of E2F-1, DP-1 and E2FBP1 mRNAs during dierentiation of NEC14 cells
The changes in relative levels of E2F-1, DP-1 and E2FBP1 mRNAs during dierentiation of NEC14 cells were analysed. Poly(A)-containing RNAs were prepared from NEC14 cells after treatment with HMBA for various times and aliquots of them were subjected to electrophoresis. After transfer of the RNAs to nylon ®lters, relative levels of mRNAs were analysed by Northern blotting (Figure 7 ). The level of 3 kb E2F-1 mRNA unchanged during the dierentiation process until 96 h after treatment of HMBA, but decreased considerably at 120 h, when the cells were completely dierentiated. The level of DP-1 mRNA decreased within 72 h and remained at a low level thereafter. The level of E2FBP1 mRNA unchanged throughout the Figure 4 In vivo association of E2BP1 with E2F-1 and DP-1. (a) Speci®cities of antibodies raised against E2F-1 and E2FBP1. A hundred ng of GST-E2F-1, GST-E2FBP1 and GST were electrophoresed, transferred to the ®lter and antibodies to E2FBP1 and E2F-1 (KH95, Santa Cruz Biotech.) were tested for reactivity to these fusion proteins at a dilution of 1 : 2000. HRP-conjugated anti rabbit IgG and anti-mouse IgG were used as the secondary antibody, respectively at a dilution of 1 : 10000. (b) Coimmunoprecipitation of E2FBP1 with E2F-1 and DP-1. The NEC14 cell extract was ®rst immunoprecipitated with antibodies to E2F-1 and E2FBP1. These precipitates were treated with 10 ml of 0.8% DOC and aliquots of 3 ml were analysed by Western blotting using the antibodies indicated above each lane. The NEC14 cell extract (10 mg of protein) was electrophoresed in parallel  (lanes 1, 4 and 7) . The ®lters were treated with ECL-detection system and exposed to X-ray ®lm with GST-E2F-1, GST-E2FBP1 and GST-DP-1. The 32 P-labeled oligonucleotide used in (a) was incubated with 2 mg each of GST-E2F-1, GST-E2FBP1, GST-DP-1, GST and combinations of these proteins. When two to four of these proteins were added, the proteins were incubated at 48C for 1 h before addition of the oligonucleotide Figure 6 Formation of the complex at the E2F site with E2F-1 and increasing amounts of E2FBP1 and DP-1. The 32 P-labeled oligonucleotide used in Figure 5 was incubated with a constant amount of GST-E2F-1 and increasing amounts of GST (a), GST-E2FBP1 (b) and GST-DP-1 (c) as indicated above each lane. The 32 P-labeled oligonucleotide was also incubated with constant amounts of GST-E2F-1 and GST-DP-1, and increasing amounts of GST-E2FBP1 (d). The complexes formed were analysed by EMSA dierentiation process. Under the conditions, the level of b-actin mRNA was nearly constant.
E2FBP1 stimulates the E2F site-dependent transcription in cooperation with E2F-1
To see the eect of E2FBP1 on the E2F/DP-dependent transcription, NEC14 cells were transfected with the reporter plasmid pE2CAT containing the adenovirus E2 promoter and one or two of the expression vectors, pHbAPr⋅E2F-1, pHbAPr⋅BP1 and pCMVDP-1 encoding E2F-1, E2FBP1 and DP-1, respectively. CAT activities were measured at 48 h posttransfection. The transfection experiments were repeated twice and average values are presented in Figure 8 . Cotransfection with increasing amounts of the E2F-1 expression vector stimulated the E2 promoter activity along with the increase in the expression vector up to about ®vefold (Figure 8a ). The pattern of the promoter activation by E2F-1 was essentially the same, when the cells were transfected together with a constant amount of the DP-1 expression vector (Figure 8b ), although the activities were stimulated further. The amount of the DP-1 expression vector was determined to optimize the cooperation with E2F-1. When the cells were cotransfected with a constant amount of the E2FBP1 expression vector and increasing amounts of the E2F-1 expression vector (Figure 8c ), a marked stimulation was observed at the E2F-1/E2FBP1 ratio of 2. The stimulation at this particular ratio was repeatedly observed.
Re¯ecting this concentration-dependent activation, the promoter was activated eciently by E2FBP1, when the E2FBP1 expression vector alone was transfected with a particular amount (6 mg) (Figure 8d ). Either the increase or the decrease in the amount of the vector from this optimal amount resulted in the reduction in the extents of transactivation. E2FBP1 may eectively heterodimerize with endogenous members of the E2F family at a particular E2F/E2FBP1 ratio so as to stimulate the DNA binding activity. Cotransfection with increasing amounts of the E2FBP1 expression vector and a constant amount of the DP-1 expression vector (Figure 8e ) did not alter the pattern of the concentration-dependent transactivation by E2FBP1. When the cells were cotransfected with a constant amount of the E2F-1 expression vector with increasing amounts of the E2FBP1 expression vector (Figure 8f ), the extents of transactivation even decreased as compared with those caused by transfection with the E2FBP1 expression vector alone, but the maximal activation was observed again at the E2F-1/E2FBP1 ratio of 2.
Cotransfection of the cells with increasing amounts of the DP-1 expression vector did not result in activation of the promoter (Figure 8g ). Simultaneous transfection with a constant amount (4 mg) of the E2FBP1 expression vector had little eect (Figure 8h ). Cotransfection of a constant amount of the E2F-1 expression vector with increasing amounts of the DP-1 expression vector (Figure 8i ), stimulated the promoter activity in a dose dependent manner, but the stimulation was very small. These results suggest that DP-1 presents in NEC14 cells at a high level, and exogenous supply of DP-1 has little eect on relative concentration of DP-1 to the E2F family members, unless E2F-1 is supplied exogenously.
The eect of E2FBP1 on the E2F-1/DP-1 dependent transactivation of the promoter was analysed by cotransfection with constant amounts of the E2F-1 and DP-1 expression vectors and increasing amounts of the E2FBP1 expression vector (Figure 8j ). The promoter activation was again maximal at the E2F-1/ E2FBP1 ratio of 2, and the pattern of transactivation was essentially the same as that observed in Figure 8f . When the cells were cotransfected with constant amounts of E2F-1 and E2FBP1 expression vectors at the E2F-1/E2FBP1 ratio of 2 and increasing amounts of the DP-1 expression vector (Figure 8k ), the promoter activation was stimulated along with the increase in the amount of the DP-1 expression vector. The stimulatory eect of E2FBP1 on the E2F-1/DP-1 dependent transactivation is apparent, and the extents of transactivation was more than twice as compared with those observed in Figure 8i . As a control, pFN508CAT which contains the human ®bronectin promoter containing no E2F site was cotransfected with a constant amount of E2F-1 expression vector and increasing amounts of the E2FBP1 expression vector (Figure 8l ). The ®bronectin promoter was not activated by E2F-1 and E2FBP1. Under the conditions, the ®bronectin promoter was eciently activated by cotransfection with the Spl expression vector, since the promoter contains multiple GC boxes.
Discussion
The transcription factor, E2F is a group of heterodimers composed of a member of the E2F family and that of the DP-1 family. (La Thangne, 1994) . The heterodimers bind preferentially to the E2F motif than does E2F homodimer and synergistically activates the E2F ± site dependent transcription. The E2F motif has been found in many growth-related genes involved in the cell cycle progression (Nevins, 1992) . The E2F/DP-1 heterodimer also acts as a negative regulator of the E2F site-dependent transcription, when pRB or its related p107 and p130 binds to the heterodimer (Weinberg, 1995) . The functions of E2F, however, can be modulated by a variety of molecules to which E2F binds, although, little is known about cellular proteins that interact with E2F, besides the DP-1 and pRB families. In the present study, cellular proteins that interact with E2F-1 in human EC cells were analysed by isolating the cDNA clones encoding the E2F-1 binding proteins from an E. coli cDNA expression library prepared from dierentiating human EC cells, NEC14. One of the cDNA clone encodes E2FBP1 which has unusual novel properties as summarized below: (a) E2FBP1 contains the HLH motif, but lacks the basic domain usually presents at N-terminal side to the HLH motif and the zipper structure usually present at Cterminal side to the HLH motif; (b) The arrangement of hydrophobic and basic amino acids in the helix 1 and helix 2 regions is quite similar to those of Mxi and Mad (Zervos et al., 1993; Ayer et al., 1993) , but is unrelated to those of E2F-1 and DP-1; (c) Western blot analysis of the immunoprecipitates from NEC14 cell extract revealed that E2FBP1 associates with both E2F-1 and DP-1 in vivo. The heterodimer of E2FBP1 formed with E2F-1 bind to the E2F site, but the heterodimer formed with DP-1 can not; (d) E2FBP1 also lacks the acidic region involved in transactivation, while it activates E2F-site dependent transcription in cooperation with E2F-1 depending on the relative expression levels of E2F-1 and E2FBP1.
The cooperative action of E2FBP1 with E2F-1 and DP-1 was studied by transfection of NEC14 cells with the reporter plasmid pE2CAT containing the adenovirus E2 promoter together with one or two of the expression vectors encoding E2F-1, DP-1 and E2FBP1. One of the interesting features of these transfection experiments is that a maximal transactivation of the E2 promoter by E2FBP1 occurs with a particular amount (6 mg) of the expression vector (Figure 8d ). The changes in the amount of the E2FBP1 expression vector in either direction from this optimal amount resulted in the decrease in the extent of transactivation. This concentration-dependent transactivation was consistently observed. The exogenously expressed E2FBP1 may heterodimerize with a member of the E2F family in the cells most eectively at this optimal amount of the vector transfected. Overproduction of E2FBP1 may facilitate the formation of transcriptionally inactive homodimer (Figures 4b and 5b) . Similar concentration-dependent transactivation was observed, when the cells were cotransfected with expression vectors for E2F-1 and E2FBP1. An ecient transactivation was achieved by transfection with these expression vectors at the E2F-1/E2FBP1 ratio of 2 ( Figure 8c , f and j). In contrast to the transactivation of the E2 promoter by E2F-1 and E2FBP1, the transactivation by E2F-1 and DP-1 occurs along with the increase in relative amount of the E2F-1 expression vector (Figure 8b ), suggesting relative abundance of DP-1 in the cells. E2FBP1 eciently stimulates E2F-1/ DP-1 dependent transactivation and the promoter activation by E2F-1 and DP-1 was stimulated more than twice by simultaneous transfection with the E2FBP1 expression vector (compare Figure 8i with k). These results indicate that the E2F site-dependent transcription is a complex event and regulated by relative concentrations of E2F and DP-1 family members and E2FBP1.
There seems to be multiple species of protein factors that interact with E2F/DP-1 members and modify their functions. The members of pRB family, pRB, p107 and p130 bind to E2F/DP-1 heterodimers and inhibit their transactivation function. In the case of muscle cell dierentiation, the E2F complex formed with its cognate DNA sequence in the dierentiated cells was irreversibly and exclusively associated with p130 (Shin et al., 1995; Corbeil et al., 1995) . On the contrary, E2F-dependent transcription is stimulated by protein factors other than E2F/DP-1 members. In adenovirus-infected cells, the binding of E2F to two adjacent motifs within the viral E2 promoter is strengthened by the formation of the complex with the viral E4 19k protein, when E1A releases E2F from the inactive complex formed with pRB or its related proteins (Nevins, 1992) . The protooncogene product of MDM2, which has the ability to bind p53 and represses its transactivation function, has been found to have another ability to bind E2F-1 and DP-1 and stimulates the transactivation capacity of E2F/DP-1 heterodimer in a concentration-dependent manner (Martin et al., 1995) . The transfected DNA was adjusted to 20 mg per 9 cm dish by the addition of carrier DNA pHbAPr-1. (a-c) Increasing amounts of pHbAPr-E2F-1 were cotransfected with or without pCMV-DP-1 or pHbAPr-E2FBP1. (d-f) Increasing amounts of pHbAPr-E2FBP1 were cotransfected with or without pHbAPr-E2F-1 or pCMV-DP-1. (g-i) Increasing amounts of pCMV-DP-1 were cotransfected with or without pHbAPr-E2F-1 or pHbAPr-E2FBP1. (j, k) Increasing amounts of pHbAPr-E2FBP1 or pCMV-DP-1 were cotransfected with two other expression vectors as indicated below. (l) As a control, pFN508CAT containing the human ®bronectin promoter which has no E2F site was transfected as the reporter plasmid instead of pE2CAT. CAT activities were determined at 48 h after transfection and shown as fold of activation over control cells that were transfected with the reporter plasmid alone. Each value is the average of the duplicate determinations interaction occurs between the N-terminal portion of MDM2 and the speci®c amino acid sequence adjacent to the pRB binding site within the E2F-1 transactivation domain. The mode of stimulation of the E2F sitedependent transcription by E2FBP1 is dierent from that caused by MDM2, since E2F-1 and E2FBP1 heterodimerize through their HLH motifs.
The structure of E2FBP1 is reminiscent of Id (inhibitor of dierentiation), which has the HLH motif but lacks the basic and transactivation domains (Benezra et al., 1990) . Id acts, however, in an opposite way and inhibits the DNA binding of some bHLH transcription factors such as MyoD, E12 and E47 by binding to them through its HLH motif. An HLH protein that inhibits the DNA binding capacity of E2F members has not yet been identi®ed. The level of Id decreases steeply in NEC14 cells as well as in myoblasts shortly after induction of dierentiation Benezra et al., 1990) , to activate the bHLH transcription factors required for transcription of the dierentiation-related genes. In contrast, the level of E2FBP1 is unchanged throughout the dierentiation process, as does DP-1 in dierentiating F9 EC cells (La Thange, 1994) . However, E2FBP1 may exert its regulatory function on the E2F activity depending on the concentration of the E2F family members, since E2FBP1 exhibits its maximal cooperative activity at the narrow range of the E2F-1/E2FBP1 ratio. The level of E2F-1 mRNA decreases after late stage of NEC14 cell dierentiation, which may result in a signi®cant reduction in the E2F site-dependent transactivation.
Materials and methods
Cell culture
The human embryonal carcinoma (EC) cell line, NEC14, derived from testicular germ cell tumors (Sekiya et al., 1985) , was cultivated in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS). The medium was changed every day and the cells were subcultivated by repeated pipetting at a 1 : 3 dilution when they had reached con¯uence. Dierentiation of NEC14 cells was induced by the addition of 10 72 M N,N'-hexamethylene-bis-acetamide (HMBA) (Sekiya et al., 1990; Hasegawa et al., 1991) .
Isolation of E2FBP1 cDNA by screening a human EC cell library
A human cDNA library was constructed from the mixture of NEC14 cells treated with 10 72 M HMBA for 0, 0.25, 0.5, 1, 2, 4, 8 and 16 h by using the E. coli expression vector lZAPII, and the Gigapack II packaging extracts (Stratagene). The cDNA library was plated at about 5610 4 recombinants per 137 mm dish and incubated at 428C for 3 ± 4 h until visible plaques were developed. The nitrocellulose ®lters soaked with 20 mM isopropyl-b-Dthiogalactopyranoside (IPTG) were overlaid on the plates and the protein expression was induced at 378C overnight. The ®lters were rinsed in 10 mM Tris-HCl (pH 7.5) containing 150 mM MgCl 2 , 1 mM KCl and 5 mM dithiothreitol (DTT) at room temperature for 30 min and in HBB buer (20 mM HEPES-KOH, pH 7.5, 5 mM MgCl 2 , 1 mM KCl, 5 mM DTT) at 48C for 10 min. The ®lters were then blocked in HBB buer supplemented with sterilized 5% dry milk at 48C for 30 min, and incubated in BB buer (20 mM HEPES-KOH, pH 7.5, 50 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.1% Nonidet P-40) supplemented with sterilized 1% dry milk and 2.5610 5 c.p.m. ml 71 of 32 Plabeled GST-E2Fb and GST-E2Fc (Figure 2a ) as probes at 48C for 4 ± 5 h. The ®lters were washed in PBS-T buer (8.1 mM NaHPO 4 , 137 mM NaCl, 2.7 mM KCl, 0.2% Triton X-100) once at 48C for 10 min and in PBS-T buer containing 0.1 M KCl three times at 48C for each 10 min. Positive clones were identi®ed by autoradiography and two further rounds of plaque puri®cation and hybridization were repeated. One of the cDNA clone designated E2FBP1 was ®nally isolated and sequenced by the dideoxynucleotide chain termination method (Sanger et al., 1977) .
Construction of plasmids encoding the E2F-1 and E2FBP1 fragments The plasmid pBSK-BP3B containing the human E2F-1 cDNA (Helin et al., 1992) was used in polymerase chain reaction (PCR) with the upstream sense primer containing the nucleotide sequence from 268 ± 287 fused to the BamHI recognition sequence, and the downstream antisense primer containing the sequence from 1314 ± 1294 fused to the EcoRI recognition sequence. The PCR product was ligated into the BamHIEcoRI site of pGEX-2TK to generate pGST-E2Fb ( Figure  2a ) which encodes the E2F-1 fragment from aa 90 ± 437. The plasmid pGEX-2TK (Kaelin et al., 1992) contains the oligonucleotide encoding the aa sequence RRASV for recognition by cAMP dependent kinase between the thrombin recognition sequence and the multicloning site (MCS) of pGEX-2T, and was used for preparation of fusion proteins with glutathione S-transferase (GST)-RRASV leader polypeptide. pGST-E2Fb was then cleaved with BamHI and BglII and the 0.6 kilobase (kb) fragment encoding the E2F-1 sequence from aa 90 ± 284 was subcloned into the BamHI site of pGEX-2TK to generate pGST-E2Fc. The remaining BamHI-BglII fragment containing the vector DNA, GST cDNA and E2F-1 cDNA fragment encoding the E2F-1 fragment from aa 285 ± 437 was self-ligated to generate pGST-E2Fd.
Bluescript SK(7)-BP1 was excised from a recombinant phage, after co-infection of XL1-Blue cells with the recombinant and the helper phages according to the manufacturer's instruction (Stratagene). The DNA was cleaved with EcoRI and the small fragment encoding the E2FBP1 sequence from aa 1 ± 58 was eliminated and the remaining DNA was self-ligated. The DNA was then cleaved with BamHI and EcoRV and the DNA fragment encoding the E2FBP1 sequence from aa 59 ± 409 was recloned into BamHISmaI site of pGEX-2TK to generate pGST-BP1a (Figure 3a) . Bluescript SK(7)-BP1 was also cleaved with PstI and the 0.7 kb fragment encoding the E2FBP1 sequence from aa 31 ± 272 was cloned into the Bluescript IIKS(+). The DNA was then cleaved with BamHI and EcoRV and recloned into BamHI-SmaI site of pGEX-2TK to generate pGST-BP1b. The PstI cleaved Bluescript SK(7)-BP1 DNA lacking the 0.7 kb fragment was self-ligated, and cleaved with BamHI and EcoRV. The BamHI-EcoRV fragment encoding the E2FBP1 sequence from aa 273 ± 409 was then cloned into the BamHISmaI site of pGEX-2TK to generate pGST-BP1d. For construction of pGST-BP1c, the E2FBP1 cDNA fragment encoding the aa sequence from 216 ± 353 was synthesized by PCR using the upstream sense primer containing the sequence from 645 ± 665 fused to the BamHI recognition sequence and the downstream antisense primer containing the sequence from 1061 ± 1044 fused to the EcoRI recognition sequence. The product was cleaved with BamHI and EcoRI and inserted into the BamHI-EcoRI site of pGEX-2TK.
Construction of E2F-1 and E2FBP1 expression vectors
The plasmid pBSK-BP3B was cleaved with BamHI and the BamHI fragment containing the E2F-1 cDNA was inserted at the BamHI site of pHbAPr-1 (Gunning et al., 1987) to generate pHbAPr-E2F-1. The plasmid pBSIIKS-BP1 was cleaved with EcoRV and the EcoRV fragment containing the E2FBP1 cDNA was ligated to the BamHI linkers after conversion of the cohesive termini to blunt ends. The fragment was then cleaved with NotI to remove a small fragment containing the plasmid sequence and ligated to the SalI linkers, after the termini were blunt-ended. The fragment was then cleaved with SalI and BamHI and inserted at the SalI-BamHI site of pHbAPr-1 to generate pHbAPr-E2FBP1.
Preparation of 32 P-labeled GST fusion proteins
The GST fusion protein produced in E. coli was puri®ed on glutathione-Sepharose as described (Smith and Johnson, 1988) . The fusion protein was phosphorylated in a 60 ml reaction mixture containing HMK buer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 12 mM MgCl 2 , 10 mg of the GST fusion protein, 185 kBq of [g-32 P]ATP, 1 mM DTT, 50 U of the catalytic subunit of cAMP-dependent protein kinase (Sigma) at room temperature for 30 min. The reaction was terminated by the addition of 40 ml of stop buer (10 mM sodium phosphate, pH 8.0, 10 mM sodium pyrophosphate, 10 mM EDTA, 1 mg ml 71 of bovine serum albumin [BSA] ) and the mixture was applied on a Sephadex-G50 column. 32 P-labeled GST fusion protein was eluted by centrifugation of the column at 48C for 5 min. Expression of GST fusion proteins in E. coli and puri®cation on glutathioneSepharose was performed as described by Kaelin et al. (1992) .
In vitro protein binding assay GST fusion proteins were electrophoresed on SDS-10% polyacrylamide gels at 180 V for 2.5 h and transferred to nitrocellulose ®lters. The proteins were denatured by incubating the ®lters in 50 ml of HBB buer containing 6 M guanidinium hydrochloride at 48C for 5 min. The proteins were then renatured successively in HBB buer containing a 1 : 2 serial dilution of guanidinium hydrochloride from 6 M to 0.1875 M each at 48C for 5 min. The ®lters were blocked with 5% sterilized dry milk (Difco) at 48C for 30 min and reacted with 32 P-labeled GST fusion proteins in BB buer (20 mM HEPES-KOH, pH 7.5, 50 mM KCl, 5 mM MgCl 2 1 mM DTT and 0.1% Nonidet P40) supplemented with 1% dry milk at 2.5610 5 c.p.m. ml 71 at 48C for 4 h. The ®lters were washed in PBS-T buer at 48C for 10 min and autoradiographed with an intensifying screen at 7808C.
Preparation of antibody
For preparation of anti-E2FBP1 antibody, GST-E2FBP1a fusion protein produced in E. coli was puri®ed through glutathione-Sepharose column and used to immunize rabbits. The rabbit antisera obtained were passed through glutathione-Sepharose column preloaded with GST and thē ow-through fraction was used as anti-E2FBP1 polyclonal antibody.
Immunoprecipitation
Immune complexes were prepared essentially according to Ikeda et al. (1996) . The NEC 14 cell extract (200 mg of protein) was mixed with 1 mg of either anti-E2FBP1 polyclonal antibody or anti-E2F-1 mouse monoclonal antibody KH95 (Santa Cruz Biotech) and incubated at 48C for 1 h with rocking. The mixture was added with 20 ml (50% v/v) of protein A-Sephrose beads and further incubated at 48C for 1 h. After centrifugation, the immune complex was washed with IP washing buer (20 mM HEPES-KOH, pH 7.9, 100 mM KCl, 6 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, 0.1 mM PMSF and 10 mg ml 71 each of aprotinin, antipain, and leupeptin) and treated with 20 ml of 0.8% deoxycholate (DOC) in IP washing buer to dissociate the E2F complexes on ice. After addition of 5 ml of 6% NP40, the mixture was centrifuged and the supernatant was used for Western blot analysis.
Western blotting
Aliquots of whole NEC14 cell extract or its immunoprecipitates were electrophoresed on 8% polyacrylamide gels with Laemmli running buer (25 mM Tris⋅glycine, pH 8.3 and 0.1% SDS). Proteins were electrophoretically transferred to nitrocellulose membranes (BA85, Schleicher & Schuell, Dassel, Germany) and incubated in immunoblotting diluent solution (3% gelatin, 100 ng of goat IgG ml 71 and 0.1% Tween 20 in PBS) at room temperature for 1 h to minimize nonspeci®c binding of antibodies. The membrane was incubated with primary antibody at an appropriate dilution as indicated in ®gure legends at room temperature for 1 h and washed three times in PBS containing 0.1% Tween 20 for 15 min. The membrane was then incubated with secondary antibody at an appropriate dilution at room temperature for 1 h and washed three times in PBS containing 0.1% Tween 20 for 15 min. Immune complexes were detected by enhanced chemiluminescence (ECL) by treating the membrane with ECL-detection system according to the manufacturers' protocol (Amersham Corp.) and exposed to X-ray ®lm (Fuji-RX, Fuji-®lm, Japan).
Electrophoretic mobility shift assays (EMSAs)
Formation of DNA-protein complexes was performed in a 10 ml reaction mixture containing 20 mM HEPES-KOH, pH 7.5, 40 mM KCl, 1 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 1 mg of sonicated salmon sperm DNA, 1 mg of poly(dA-dT)⋅poly(dA-dT), 0.5 fmol (5610 3 c.p.m.) of 32 P-labeled oligonucleotide containing the human N-myc promoter sequence from 7203 to 7161 and 4 mg protein of NEC14 nuclear extract (Andrew and Faller, 1991) in the presence or absence of anti-E2F-1 antibody KH95, anti-DP1 antibody K-20 (Santa Cruz Biotech) or anti-E2FBP1 polyclonal antibody at room temperature for 20 min. DNA-protein complexes were resolved by electrophoresis on 5% polyacrylamide gels at 258C for 2 h at 200 V in 0.56TBE buer (12.5 mM Tris-borate, pH 8.3, 0.25 mM EDTA). The gels were dried and autoradiographed with an intensifying screen at 7808C.
The oligonucleotide, 7203 CAAAGAAAAGCAAGTGGCT-TTTGGCGCGAAAGCCTTGGCGCCT 7161 containing two overlapping E2F motifs as shown by the underline was synthesized on an Applied Biosystems DNA synthesizer, and puri®ed by oligonucleotide puri®cation cartridge (OPC) columns (Applied Biosystems). Two complementary singlestranded oligonucleotides were annealed in 10 mM Tris-HCl, pH 7.5 containing 1 mM EDTA and 0.2 M NaCl and end labeled with T4 polynucleotide kinase in the presence of [g-32 P]ATP. The oligonucleotides were electrophoresed on a 15% nondenaturating polyacrylamide gel and the doublestranded probe was isolated.
Transient gene expression
DNA transfection was performed by the CaPO 4 coprecipitation procedure modi®ed by Chen and Okayama (1987) . Subcon¯uent cultures of NEC14 cells were transfected with the reporter plasmid pE2CAT and expression vectors encoding E2F-1, DP-1 or E2FBP1 in a total DNA amount of 20 mg. CAT activity was assayed at 48 h after transfection according to Gorman et al. (1982) . Four hundred mg protein of the cell extract were used for each assay.
Northern blot hybridization
Total cellular RNA was prepared by the AGPC (acid guanidinium thiocyanate-phenol-chloroform) extraction method (Chomczynski and Sacchi, 1987) . Poly(A)-containing mRNA was prepared by using Oligotex(dT) 30 (Hara et al., 1995) . RNA was subjected to electrophoresis in 1% agarose gels in buer containing 2.2 M formaldehyde, 20 mM MOPS (3-(N-Morpholino) propanesulfonic acid) (pH 7.0), 8 mM sodium acetate, and 1 mM EDTA and transferred to nylon membrane ®lters. Hybridization was carried out by adding 10 6 c.p.m. ml 71 of 32 P-labeled DNA probe. The E2F-1 and DP-1 cDNAs were prepared by cleavage of pBSK-BP3B with BamHI and by cleavage of pCMVDP-1 with EcoRI and XhoI, respectively. The E2FBP1 cDNA was prepared by cleavage of Bluescript SK-BP1 with BamHI and XhoI.
32 P-labeling was carried out by the multiprime DNA labeling system.
